FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Info Collection for Fellowship/Traineeship Programs

Federal Register notice: FDA seeks comments on a proposed Collection of Information for Participation in FDA Non-Employee Fellowship and Traineeship P...

Human Drugs

FDA Chief Counsel Amin Resigns

FDA chief counsel Stacy Cline Amin resigns after leading the agencys legal shop for over two years.

Human Drugs

Fresenius Kabi Recalls 1 Lot of Ketorolac Tromethamine

Fresenius Kabi USA recalls one lot of ketorolac tromethamine injection, 30 mg/mL, 1 mL fill in a 2 mL amber vial, due to the presence of particulate m...

Human Drugs

sNDA for Jardiance to Reduce Cardiovascular Death/Hospitalization

FDA accepts a Boehringer Ingelheim and Eli Lilly supplemental NDA for Jardiance (empagliflozin) for reducing the risk of cardiovascular death and hosp...

Medical Devices

Boston Scientific Recalls Lotus Edge Aortic Valve

Boston Scientific recalls all unused inventory of its Lotus Edge Aortic Valve System due to complexities associated with the product delivery system....

Federal Register

20 Drug Determinations on ANDA Availability

Federal Register notice: FDA determines that 20 drug products were not withdrawn from sale for reasons of safety or effectiveness, which makes them av...

Federal Register

Bulk Drug Substance Listing Reopened for Comments

Federal Register notice: FDA reopens the comment period for a notice that appeared in the 7/31/2020 Federal Register in which FDA identified certain b...

Human Drugs

All Drugs Approved in 2020 Met User Fee Goals: FDA

FDA says that all 53 new molecular entity approvals in 2020 were acted on by or before their user fee goal dates.

Federal Register

Info Collection on FDA Recall Regulations

Federal Register notice: FDA seeks comments on an information collection extension entitled FDA Recall Regulations 21 CFR Part 7.

Human Drugs

FDA Hits Neoleukin with Clinical Hold on Immunotherapy

FDA issues a clinical hold on a Neoleukin Therapeutics Phase1 clinical trial of its immunotherapeutic candidate, NL-201, requesting a new assay to mea...